Angiotensin I-converting enzyme in cerebrospinal fluid and neurosarcoidosis;Enzyme de conversion de l'angiotensine I dans le liquide céphalorachidien et neurosarcoïdose

Annales de Biologie Clinique

Volumn 63, Issue 5, 2005, Pages 475-480

  Baudin, B ^a   Beneteau Burnat B ^a   Vaubourdolle, M ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Angiotensin I converting enzyme; Cerebrospinal fluid; Neurological disorder; Radiometry; Sarcoidosis

Indexed keywords

BIOLOGICAL MARKER; DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; NEUROLOGIC DISEASE; REFERENCE VALUE; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NERVOUS SYSTEM DISEASES; PEPTIDYL-DIPEPTIDASE A; REFERENCE VALUES; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY;

EID: 30744458342     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Newman LS, Rose CS, Meier LA. Review : sarcoidosis. N Engl J Med 1997 ; 336 : 1224-34 ; Erratum in. N Engl J Med 1997 ; 337 : 139.
2. Nowak DA, Widenka DC. Neurosarcoidosis : a review of its intracranial manifestation. J Neurol 2001 ; 248 : 363-72.
3. Oksanen V. Neurosarcoidosis : clinical presentations and course in 50 patients. Acta Neurol Scand 1986 ; 73 : 283-90.
4. Oksanen V. New cerebrospinal fluid, neurophysiological and neuroradiological examinations in the diagnosis and follow-up of neurosarcoidosis. Sarcoidosis 1987 ; 4 : 105-10.
5. Ainslie GM, Benatar SR. Serum angiotensin-converting enzyme in sarcoidosis : sensitivity and specificity in diagnosis : correlations with disease activity, duration, extra-thoracic involvement, radiography type and therapy. Q J Med 1985 ; 55 : 253-70.
6. Bénéteau-Burnat B, Baudin B. Angiotensin-converting enzyme : clinical applications and laboratory investigations on serum and other biological fluids. Crit Rev Clin Lab Sci 1991 ; 28 : 337-56.
7. Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin-converting enzyme activity in serum in sarcoidosis. Thorax 1986 ; 41 : 629-34.
8. 67Ga scanning for assessment of disease activity and therapy decisions in pulmonary sarcoidosis in comparison to chest radiography, serum ACE and blood T-lymphocytes. Eur J Nucl Med 1982 ; 7 : 413-6.
9. Romer FK, Jacobsen F. The influence of prednisone on serum angiotensin-converting enzyme activity in patients with and without sarcoidosis. Scand J Clin Lab Invest 1982 ; 42 : 377-82.
10. Perrin-Fayolle M, Pacheco Y, Harf R, Montagnon B, Biot N. Angiotensin-converting enzyme in bronchoalveolar lavage fluid in pulmonary sarcoidosis. Thorax 1981 ; 34 : 790-2.
11. 14C]hippuryl-L-histidyl-L-leucine : a substrate for the radiochemical assay of angiotensin-converting enzyme. Anal Biochem 1978 ; 84 : 272-6.
12. Cartier P. Le dosage des metabolites par la méthode de "cinétique enzymatique - dilution isotopique". Ann Biol Clin 1975 ; 33 : 127-9.
13. Bénéteau-Burnat B, Baudin B, Giboudeau J. Radiometric determination of angiotensin I-converting enzyme activity in human bronchoalveolar lavage and cerebrospinal fluids and in aqueous humor for the management of sarcoidosis. Clin Chem Enzym Comms 1996 ; 7 : 167-75.
14. Nakamura A, Ohara S, Maruyama K, Takei Y, Shindo M, Yanagisawa N. Systemic sarcoidosis : a case with a focal hydrocephalus and elevated lysozyme and angiotensin-converting enzyme in the cerebrospinal fluid. J Neurol 1999 ; 246 : 320-2.
15. Oksanen V, Fyhrquist F, Somer H, Grönhagen-Riska C. Angiotensin-converting enzyme in cerebrospinal fluid : a new assay. Neurology 1985 ; 35 : 1220-3.
16. Dale JC, O'Brien JF. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis [letter]. Mayo Clin Proc 1999 ; 74 : 535.
17. Chan Seen CP, Norfolk G, Spokes EG. CSF angiotensin-converting enzyme in neurosarcoidosis [letter]. Lancet 1985 ; Feb 23 : 456-7.
18. Oksanen V, Fyhrquist F, Grönhagen-Riska C, Somer H. CSF angiotensin-converting enzyme in neurosarcoidosis [reply to the former letter]. Lancet 1985 ; May 4 : 1050-1.
19. Schweisfurth H, Schiöberg-Schiegnitz S, Kuhn W, Parusel B. Angiotensin I-converting enzyme in cerebrospinal fluid of patients with neurological diseases. Klin Wochenschr 1987 ; 65 : 955-8.
20. Baudin B, Mario N, Robic D, Giboudeau J. Angiotensin I-converting enzyme molecular mass by size-exclusion high-performance liquid chromatography and capillary electrophoresis. Int J Bio-Chromatogr 1996 ; 2 : 109-18.
21. Baudin B. Enzyme de conversion de l'angiotensine I. In : Cahier de formation, assurance de qualité - Tome III. Paris : Société Française de Biologie Clinique, 1997 : 109-19.
22. Mordelet-Dambrine MS, Stanislas-Leguern GM, Huchon GJ, Baumann FC, Marsac J, Chrétien J. Elevation of the bronchoalveolar concentration of angiotensin I-converting enzyme in sarcoidosis. Am Rev Res Dis 1982 ; 126 : 472-5.
23. Schweisfurth H, Schiöberg-Schiegnitz S. Assay and biochemical characterization of angiotensin I-converting enzyme in cerebrospinal fluid. Enzyme 1984 ; 32 : 12-9.
24. Hooper NM. Angiotensin-converting enzyme : how reliable is the fluorimetric assay with benzoyl-Gly-His-Leu as substrate ? Biochem J 1990 ; 270 : 840-1.
25. Yoshida T, Nosaka S. Some characteristics of a peptidyl-dipeptidase (kininase II) from rat CSF : differential effects of NaCl on the sequential degradation steps of bradykinin. J Neurochem 1990 ; 55 : 1861-9.
26. Wahlbeck K, Ahokas A, Nikkilä H, Miettinen K, Rimon R. Cerebrospinal fluid angiotensin-converting enzyme (ACE) correlates with length of illness in schizophrenia. Schizophr Res 2000 ; 41 : 335-40.
27. Briddon A. Angiotensin-converting enzyme activity in cerebrospinal fluid (CSF). Clin Chem 1992 ; 38 : 439.
28. Hurst PL, Lovell-Smith CJ. Optimized assay for serum angiotensin- converting enzyme activity. Clin Chem 1981 ; 27 : 2048-52.
29. Oksanen V, Grönhagen-Riska C, Fyhrquist F, Somer H. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement. Acta Med Scand 1985 ; 218 : 123-7.
30. Baudin B, Bénéteau-Burnat B, Crayon B, Giboudeau J. Automated kinetic assay of angiotensin-converting enzyme on Synchron CX-4. Clin Chem Enzym Comms 1995 ; 7 : 41-8.
31. Bénéteau B, Baudin B, Morgant G, Giboudeau J, Baumann FC. Automated kinetic assay of angiotensin-converting enzyme in serum. Clin Chem 1986 ; 32 : 884-6.
32. Baudin B. New aspects on angiotensin-converting enzyme : from gene to disease. Clin Chem Lab Med 2002 ; 40 : 256-65.
33. Baudin B, Giboudeau J. Carboxypeptidase A hydrolyses benzoylglycyl- histidyl-leucine but not furylacryloyl-phenylalanylglycyl-glycine, two usual substrates for angiotensin I-converting enzyme. Enz Prot 1994-1995 ; 48 : 81-9.
34. Bénéteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J. Serum angiotensin-converting enzyme in healthy and sarcoidotic children : comparison with the reference interval for adults. Clin Chem 1990 ; 36 : 344-6.
35. Faure-Delanef L, Baudin B, Bénéteau-Burnat B, Beaudoin JC, Giboudeau J, Cohen D. Plasma concentration, kinetic constants, and gene polymorphism of angiotensin I-converting enzyme in centenarians. Clin Chem 1998 ; 44 : 2083-97.
36. Plassart F, Cynober L, Baudin B, et al. Plasma fibronectin and angiotensin-converting enzyme : markers of primary pulmonary injury in burn patients. Clin Chim Acta 1994 ; 227 : 135-44.